Daniel R. Doerge Data-verified

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

High Impact

Researcher

NCTR

Last publication 2023 Last refreshed 2026-05-16

faculty

76 h-index 339 pubs 19,546 cited

Research Areas

Links

ORCID Google Scholar Lab Website

OverviewAI-generated summary

Daniel R. Doerge's research focuses on the toxicological effects and metabolic pathways of various compounds, with a particular emphasis on their impact in animal models, including rats and mice. His work has investigated the toxicokinetics of polyfluorinated compounds in pregnant and nonpregnant rats, examining how the body processes these substances following oral exposure. Additionally, Doerge has studied the effects of isoflavones, such as genistein and isoliquiritigenin, on biological processes. His research on genistein has explored its influence on mammary tumor response to tamoxifen in rats, while isoliquiritigenin has been examined for its role in decreasing bone resorption and osteoclast differentiation.

Doerge's extensive publication record, with over 339 publications and a citation count exceeding 19,000, indicates a significant contribution to the field of toxicology and pharmacology. He is recognized as a highly cited researcher. His collaborations include researchers from the National Center for Toxicological Research, such as Volodymyr Tryndyak, Frederick A. Beland, Michelle M. Vanlandingham, and Mona I. Churchwell, with whom he has co-authored publications. Doerge maintains an active laboratory website to share his research findings.

Metrics

h-index: 76
Publications: 339
Citations: 19,546

Selected Publications

Evaluating the toxicokinetics of some metabolites of a C6 polyfluorinated compound, 6:2 fluorotelomer alcohol in pregnant and nonpregnant rats after oral exposure to the parent compound (2023)

7 citations DOI OpenAlex
Isoliquiritigenin Decreases Bone Resorption and Osteoclast Differentiation (2022)

6 citations DOI OpenAlex